Eton Pharmaceuticals Inc. (ETON)
NASDAQ: ETON
· Real-Time Price · USD
17.01
0.31 (1.86%)
At close: Aug 15, 2025, 3:59 PM
17.04
0.18%
After-hours: Aug 15, 2025, 04:10 PM EDT
Eton Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.58M | -1.57M | -598K | 627K | -3.04M | -811K | -2.26M | -579K | 4.56M | -2.66M | 912K | -3.04M | -1.56M | -5.33M | 1.04M | -6.09M | -2.02M | 5.12M |
Depreciation & Amortization | 1M | 1.01M | 355K | 278K | 261K | 277K | 275K | 202K | 211K | 213K | 252K | 170K | 1.17M | 181K | 137K | 85K | 85K | 155K |
Stock-Based Compensation | 2.1M | 1.2M | 782K | 722K | 840K | 821K | 750K | 730K | 785K | 872K | 886K | 949K | 1.3M | 1.08M | 863K | 1.01M | 836K | 673K |
Other Working Capital | n/a | 9.86M | -2.62M | 1.32M | 3.65M | -938K | 1.26M | 1.73M | 1.04M | 1.43M | 477K | 1.05M | 1.66M | 931K | -393K | -564K | 1.37M | -1.32M |
Other Non-Cash Items | 7.44M | 1.45M | 1.06M | 39K | 59K | n/a | 27K | 29K | 32K | 29K | 31K | 30K | 30K | 36K | 38K | 37K | 37K | 36K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -546K | n/a |
Change in Working Capital | n/a | -4K | -2.36M | 1.29M | 3.14M | -2.76M | 1.59M | 491K | 1.52M | -2K | 759K | 193K | 1.52M | 5.25M | -7.19M | 2.01M | 1.24M | -2.27M |
Operating Cash Flow | 7.96M | 2.09M | -765K | 2.95M | 1.25M | -2.47M | 387K | 873K | 7.1M | -1.55M | 2.84M | -1.7M | 2.46M | 1.22M | -5.12M | -2.95M | -369K | 3.71M |
Capital Expenditures | n/a | n/a | -8.13M | 1.87M | n/a | -1.88M | -775K | n/a | n/a | n/a | -12K | -2M | -761K | -15K | -3.25M | -2K | -3K | n/a |
Cash Acquisitions | n/a | n/a | -30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 700K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -8.12M | -1.87M | n/a | n/a | n/a | n/a | n/a | n/a | -2.75M | -2M | -750K | n/a | -3.25M | n/a | 700K | n/a |
Investing Cash Flow | n/a | n/a | -38.13M | n/a | n/a | -1.88M | -775K | n/a | n/a | n/a | -12K | -2M | -761K | -15K | -3.25M | -2K | 697K | n/a |
Debt Repayment | n/a | n/a | 25.31M | -385K | -385K | -385K | -385K | -385K | -385K | n/a | n/a | n/a | n/a | -385K | n/a | -150K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -181K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 248K | n/a | n/a | n/a | 181K | n/a | 139K | -49K | 99K | 35K | 117K | n/a | 68K | 9K | 361K | 103K |
Financial Cash Flow | n/a | 394K | 33.57M | -385K | -216K | -378K | -294K | -368K | -246K | -49K | 99K | 35K | 117K | -385K | 68K | -141K | 361K | 103K |
Net Cash Flow | 7.96M | 2.48M | -5.33M | 2.57M | 1.04M | -4.73M | -682K | 504K | 6.86M | -1.6M | 2.93M | -3.67M | 1.82M | 823K | -8.3M | -3.09M | 689K | 3.82M |
Free Cash Flow | 7.96M | 2.09M | -8.9M | 4.82M | 1.25M | -4.36M | -388K | 873K | 7.1M | -1.55M | 2.83M | -3.7M | 1.7M | 1.21M | -8.37M | -2.95M | -372K | 3.71M |